Breaking News: European Study Reports Halting of Progress of Type 1 Diabetes by Drug Anti-CD3 AntibodyJuly 17th, 2005 The European study of patients with Type I diabetes found that short-term treatment lowered insulin dependence by 12 percent and increased insulin-making capabilities for at least 18 months. "The results are very promising.
WHO projects Diabetes will affect 370m by 2030 (currently 177m) worldwideApril 4th, 2005 A diabetes epidemic is under way. According to the World Health Organization (WHO), an estimated 30m people worldwide had some form of diabetes in 1985; by 2000, the number had increased to 177m.
Two new clinical trials for NASH (Nonalcoholic Steatohepatitis) treatment with Vitamin E, Metformin and PioglitazoneApril 4th, 2005 NASH, a liver disease that resembles alcoholic liver disease but occurs in patients who drink little or no alcohol. NASH occurs most often in adults over the age of 40 who are overweight or have diabetes, insulin resistance (pre-diabetes), or hyperlipidemia (excess concentrations of fatty materials in the blood).
Diabetes Cure PossibleJune 18th, 2006 Cure for diabetes could be around the corner after US scientists found cells from the spleen can transform into insulin-producing cells. US researchers were able to halt, and even reverse, the disease in mice.
Immune System re-education may be the best hope for diabetes cureMarch 14th, 2005 A discussion on immune system re-education results.
Volunteers Needed for Inhaled Insulin StudyJuly 27th, 2005 Researchers at Indiana University School of Medicine are looking for 400 people with type 1 diabetes to volunteer for a study of an inhaled insulin treatment. The Indiana University School of Medicine is one of 70 sites around the world testing the treatment developed by Indianapolis-based Eli Lilly and Co.
Research finds Statin simvastatin appears to prevent or reverse vascular injury in diabetic ratsApril 3rd, 2005 Since most patients with diabetes die from some vascular complication, Medical College of Georgia researchers set out to determine the effects of simvastatin on endothelial cell dysfunction, an early pivotal event in atherogenesis and a major cause of the microvascular complications in diabetics. The researchers found that in addition to lowering cholesterol levels, simvastatin also appeared to prevent or reverse vascular injury by vasoprotective means.
New Therapy for Diabetic Peripheral Neuropathy using monochromatic infrared photo energyApril 7th, 2005 for those afflicted with Diabetic Peripheral Neuropathy (DPN), Missouri Southern Healthcare has a new therapy program that has shown great strides in returning circulation to feet, lowering the pain and frequency of falls that most people with diabetes suffer. The therapy must be given in 40-minute increments three times a week for 10 to 20 weeks.
Excessive Sleepiness May Signal Depression, Diabetes or ObesitySeptember 7th, 2005 Doctors commonly view excessive daytime sleepiness as a cardinal sign of disturbed or inadequate sleep. But a new study suggests it could also signal depression or even diabetes or obesity, regardless of whether an individual doesn't sleep well.
Simple Thoughts Blog Selected in Top 100 Blogs by FeedsterAugust 17th, 2005 I am happy to announce that The Simple Thoughts Blog is ranked 97 in Feedster's Top 500 List. A big round of applause for my readers and fellow bloggers who helped us achieve this distinction.
INGAP closer to cure diabetesMarch 18th, 2005 LOS ANGELES -- Researchers might be getting closer to finding a cure for diabetes. Researchers announced a new treatment and medicine, and the discovery of a gene that might play a role.
Do you have diabetes? Are you sure?April 5th, 2005 According to University of Washington about 10 million US citizens have diabetes without being aware of it. Diabetes is the most insidious disease.
Ruboxistaurin (RBX) May Reduce Risk of Vision Loss in DiabeticsJuly 16th, 2005 A multicenter international study chaired by a Joslin Diabetes Center investigator and reported in the July issue of the American Diabetes Association’s journal Diabetes brings hopeful news to the 18 million people in the United States -- and millions more worldwide -- with type 1 or type 2 diabetes. Initial results of the Phase III clinical trial demonstrated that 32 milligrams per day of ruboxistaurin (RBX) was well tolerated and may reduce the risk of moderate vision loss, especially in patients with diabetic macular edema.
Top 5 Gadgets for Diabetes PatientsApril 11th, 2009 What can not be cured must be endured. And diabetes perfectly fits in to this category.
Tingling Feet may Lead-up to DiabetesSeptember 13th, 2005 University of Utah researchers have determined tingling in the feet (neuropathy) could be an early warning indicator for impaired glucose tolerance, or prediabetes. 67 patients underwent nerve conduction studies as well as a series of other neuropathy testing.